GSK ZOSTER

A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) when administered intramuscularly on a two-dose schedule to immunocompromised paediatric renal transplant recipients from 1 to 17 years of age.

1517-CL-1003

Phase 3, Open-Label, Uncontrolled Study for the treatment of adolescents and children with anemia associated with chronic kidney disease.

OPDC 307

A phase 3b multicenter open-label trial of the safety, tolerability, and efficacy of tolvaptan in infants and children 28 days to less than 18 years of age with autosomal recessive polycystic kidney disease (arpkd)

OPDC 204

A phase 3b multicenter open-label trial of the safety, tolerability, and efficacy of tolvaptan in infants and children 28 days to less than 12 weeks of age with autosomal recessive polycystic kidney disease (arpkd)

OGTT ADPKP

Evaluation of the glucose metabolism in early autosomal dominant polycystic kidney disease: a multicentric study

FIONA OLE 

An 18-month, open-label, single-arm safety extension study of an age-and bodyweightadjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children and young adults from 1 to 18 years of age with chronic kidney disease and proteinuria

FIONA

A 6-month multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and PK/PD of an age-and body weight-adjusted oral finerenone regimen, in addition to an ACEI or ARB, for the treatment of children, 6 months to

COMMUTE-P

A phase iii, multicenter, single-arm study evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of crovalimab in pediatric patients with atypical hemolytic uremic syndrome (ahus)

PROREAL

Multicentre, ambispetive, observational, real life study to assess the Quality of life effectiveness of ER oral cysteamine therapy (Procysbi) in Belgian patients suffering from nephropatich cystinosis

KKI XLH Registry

An international, multicentre, prospective, non-interventional observational registry for patients with X-linked hypophosphatemia

CINACALCET

An observational registry study to evaluate the use and safety of cinacalcet among paediatric patiënts with secondary hyperparathydroidism

LEARNS

Prevention of relapses with Levamisole as adjuvant therapy to corticosteroids in children with first episode of idiopathic nephrotic syndrome

PREDICT

Antibiotic propylaxis and renal damage in congenital abnormalities of the kidney and urinary tract

ALEXION REGISTRY

An observational, non-interventional, multicenter, multi-national study of patients with atypical hemolytic- uremic syndrome

Laatste aanpassing: 27 juni 2023